-
1.
公开(公告)号:US20080064699A1
公开(公告)日:2008-03-13
申请号:US11755884
申请日:2007-05-31
申请人: Alan Florjancic , Michael Dart , Keith Ryther , Arturo Perez-Medrano , William Carroll , Meena Patel , Karin Tietje , Tongmei Li , Teodozyj Kolasa , Megan Gallagher , Sridhar Peddi , Jennifer Frost , Derek Nelson
发明人: Alan Florjancic , Michael Dart , Keith Ryther , Arturo Perez-Medrano , William Carroll , Meena Patel , Karin Tietje , Tongmei Li , Teodozyj Kolasa , Megan Gallagher , Sridhar Peddi , Jennifer Frost , Derek Nelson
IPC分类号: C07D277/38 , A61K31/426 , A61K31/428 , A61K31/4427 , C07D417/02 , C07D277/62 , A61K31/5377 , A61P25/00
CPC分类号: C07D277/46 , A61K31/429 , C07D277/48 , C07D277/82 , C07D417/04 , C07D417/06 , C07D417/12 , C07D493/08 , C07D513/04
摘要: The present invention relates to compounds of formula (I), or pharmaceutically acceptable salts, prodrugs, salts of prodrugs, or combinations thereof, wherein R1, R2, R3, R4, and L2, are defined in the specification, compositions comprising such compounds, and methods of treating conditions and disorders using such compounds and compositions.
摘要翻译: 本发明涉及式(I)化合物或其药学上可接受的盐,前体药物,前药盐或其组合,其中R 1,R 2,R 2, 在本说明书中定义了含有这些化合物的组合物,以及使用这些化合物治疗病症和病症的方法,其中,R 3,R 4,R 2和L 2 和组合物。
-
公开(公告)号:US20090105306A1
公开(公告)日:2009-04-23
申请号:US12246808
申请日:2008-10-07
申请人: William A. Carroll , Michael J. Dart , Arturo Perez-Medrano , Derek W. Nelson , Tongmei Li , Sridhar Peddi , Jennifer Frost , Teodozyj Kolasa , Bo Liu , Steven P. Latshaw , Xueqing Wang
发明人: William A. Carroll , Michael J. Dart , Arturo Perez-Medrano , Derek W. Nelson , Tongmei Li , Sridhar Peddi , Jennifer Frost , Teodozyj Kolasa , Bo Liu , Steven P. Latshaw , Xueqing Wang
IPC分类号: A61K31/433 , C07D417/02 , C07D285/12 , C07D405/02 , C07D413/02 , A61P29/00 , A61P9/00 , A61P35/00 , A61P37/00 , A61P25/00 , A61K31/443 , A61K31/422 , A61K31/4155
CPC分类号: C07D405/06 , C07D405/14 , C07D413/06 , C07D413/14 , C07D417/06 , C07D417/14
摘要: The present invention relates compounds of formula (I) wherein A and R1 are as defined in the specification, pharmaceutical compositions comprising such compounds, and methods of treating conditions and disorders using such compounds and pharmaceutical compositions.
摘要翻译: 本发明涉及式(I)的化合物,其中A和R 1如说明书中所定义,包含这些化合物的药物组合物,以及使用这些化合物和药物组合物治疗病症和障碍的方法。
-
公开(公告)号:US20070037801A1
公开(公告)日:2007-02-15
申请号:US11315862
申请日:2005-12-21
申请人: Jennifer Frost , Karin Tietje , Michael Dart , Michael Meyer
发明人: Jennifer Frost , Karin Tietje , Michael Dart , Michael Meyer
IPC分类号: A61K31/5377 , A61K31/454 , A61K31/405 , A61K31/404 , A61K31/4439 , A61K31/427 , C07D417/02 , C07D405/02 , C07D413/02 , C07D403/02
CPC分类号: C07D403/06 , C07D209/12 , C07D401/06 , C07D405/06 , C07D409/06 , C07D413/06 , C07D417/06
摘要: The present invention provides novel compounds of Formula (I) which are CB2 selective ligands useful for the treatment of pain.
摘要翻译: 本发明提供了新颖的式(I)化合物,其为可用于治疗疼痛的CB 2/2选择性配体。
-
公开(公告)号:US20050234031A1
公开(公告)日:2005-10-20
申请号:US11051437
申请日:2005-02-04
申请人: Michael Schrimpf , Kevin Sippy , Jianguo Ji , Tao Li , Jennifer Frost , Clark Briggs , William Bunnelle
发明人: Michael Schrimpf , Kevin Sippy , Jianguo Ji , Tao Li , Jennifer Frost , Clark Briggs , William Bunnelle
IPC分类号: A61K31/4745 , A61K31/496 , A61K31/55 , A61K31/551 , C07D487/04
CPC分类号: C07D453/02 , C07D205/04 , C07D207/08 , C07D207/12 , C07D207/14 , C07D209/88 , C07D211/14 , C07D243/08 , C07D333/76 , C07D401/12 , C07D403/04 , C07D403/12 , C07D405/12 , C07D409/12 , C07D451/06 , C07D487/04 , C07D487/08
摘要: Compounds of formula (I) wherein A and B are amine-substituted sidechains, Y1 and Y2 form various tricyclic cores, Xa and Xb are C, CH, or N, as defined herein, and Rx is an optional substituent. Compounds and compositions of formula (I) are contemplated as well as methods for treating conditions or disorders prevented by or ameliorated by α7nAChR ligands that encompass compounds of formula (I) and other tricyclic derivatives. Methods of using amino-substituted tricyclic derivatives also are described herein.
摘要翻译: 其中A和B是胺取代的侧链,Y 1和Y 2的式(I)化合物形成各种三环核,X 1和 如本文所定义,C 1-6烷基是C,CH或N,并且R x是任选的取代基。 考虑式(I)的化合物和组合物以及用于治疗由包括式(I)化合物和其它三环衍生物的α7nAChR配体防止或改善的病症或病症的方法。 使用氨基取代的三环衍生物的方法也在本文中描述。
-
5.
公开(公告)号:US20080058335A1
公开(公告)日:2008-03-06
申请号:US11755434
申请日:2007-05-30
申请人: Alan Florjancic , Michael Dart , Keith Ryther , Arturo Perez-Medrano , William Carroll , Meena Patel , Karin Tietje , Tongmei Li , Teodozyj Kolasa , Megan Gallagher , Sridhar Peddi , Jennifer Frost , Derek Nelson
发明人: Alan Florjancic , Michael Dart , Keith Ryther , Arturo Perez-Medrano , William Carroll , Meena Patel , Karin Tietje , Tongmei Li , Teodozyj Kolasa , Megan Gallagher , Sridhar Peddi , Jennifer Frost , Derek Nelson
IPC分类号: A61K31/5377 , A61K31/4245 , A61K31/426 , A61P25/00 , A61P35/00 , A61P43/00 , C07D215/00 , C07D271/04 , C07D277/62 , C07D295/00 , C07D277/02 , C07D217/00 , A61P9/00 , A61P37/00 , A61P29/00 , A61P11/00 , A61K31/47
CPC分类号: C07D277/82 , C07D277/46 , C07D277/48 , C07D277/60 , C07D417/06 , C07D417/12 , C07D477/14 , C07D513/04
摘要: The present invention relates to compounds of formula (I), or pharmaceutical salts, prodrugs, salts of prodrugs, or combinations thereof, wherein R1, R2, R3, and L1 are defined in the specfication, compositions comprising such compounds, and methods of treating conditions and disorders using such compounds and compositions. The present invention also relates to compounds of formula (II), or pharmaceutical salts, prodrugs, salts of prodrugs, or combinations thereof, wherein R1a, R2a and (Rx)n are as defined in the specification, compositions comprising such compounds, and methods of treating conditions and disorders using such compounds and compositions.
摘要翻译: 本发明涉及式(I)化合物或其药物盐,前药,前药盐或其组合,其中R 1,R 2,R 2, > 3>和L 1>在含有这些化合物的组合物中的定义,以及使用这些化合物和组合物治疗病症和病症的方法。 本发明还涉及式(II)的化合物或药物盐,前药,前药盐或其组合,其中R 1a 1a,R 2a和(R x )n如说明书中所定义,包含这些化合物的组合物,以及使用这些化合物和组合物治疗病症和障碍的方法。
-
公开(公告)号:US09193713B2
公开(公告)日:2015-11-24
申请号:US12246808
申请日:2008-10-07
申请人: William A. Carroll , Michael J. Dart , Arturo Perez-Medrano , Derek W. Nelson , Tongmei Li , Sridhar Peddi , Jennifer Frost , Teodozyj Kolasa , Bo Liu , Steven P. Latshaw , Xueqing Wang
发明人: William A. Carroll , Michael J. Dart , Arturo Perez-Medrano , Derek W. Nelson , Tongmei Li , Sridhar Peddi , Jennifer Frost , Teodozyj Kolasa , Bo Liu , Steven P. Latshaw , Xueqing Wang
IPC分类号: C07D405/06 , C07D405/14 , C07D413/06 , C07D413/14 , C07D417/06 , C07D417/14
CPC分类号: C07D405/06 , C07D405/14 , C07D413/06 , C07D413/14 , C07D417/06 , C07D417/14
摘要: The present invention relates compounds of formula (I) wherein A and R1 are as defined in the specification, pharmaceutical compositions comprising such compounds, and methods of treating conditions and disorders using such compounds and pharmaceutical compositions.
摘要翻译: 本发明涉及式(I)的化合物,其中A和R 1如说明书中所定义,包含这些化合物的药物组合物,以及使用这些化合物和药物组合物治疗病症和障碍的方法。
-
7.
公开(公告)号:US20080097094A1
公开(公告)日:2008-04-24
申请号:US11957424
申请日:2007-12-15
申请人: Michael Schrimpf , Karin Tietje , Richard Toupence , Jianguo Ji , Anwer Basha , William Bunnelle , Jerome Daanen , Jennifer Frost , Kevin Sippy
发明人: Michael Schrimpf , Karin Tietje , Richard Toupence , Jianguo Ji , Anwer Basha , William Bunnelle , Jerome Daanen , Jennifer Frost , Kevin Sippy
IPC分类号: A61K31/55 , A61K31/4353 , A61P25/00 , C07D471/04 , C07D487/04
CPC分类号: C07D471/04 , C07D487/04
摘要: Compounds of formula I pharmaceutical compositions of these compounds, and use of said compositions to control synaptic transmission in mammals.
摘要翻译: 式I化合物,这些化合物的药物组合物,以及所述组合物用于控制哺乳动物突触传递的用途。
-
公开(公告)号:US20080058307A1
公开(公告)日:2008-03-06
申请号:US11848509
申请日:2007-08-31
申请人: Derek Nelson , Jennifer Frost
发明人: Derek Nelson , Jennifer Frost
IPC分类号: C07D495/18 , A61K31/381 , A61K31/397 , A61P25/00 , C07D205/02
CPC分类号: C07D495/18
摘要: The present invention relates to thiophene containing compounds of formula (I) wherein m, n, p, q, r, s, R1, R2, and R3 are as defined in the description. Included also are pharmaceutical compositions comprising such compounds, and methods for treating conditions and disorders using such compounds and pharmaceutical compositions.
摘要翻译: 本发明涉及含噻吩的式(I)化合物,其中m,n,p,q,r,s,R 1,R 2和R 2 > 3 SUB>如说明书中所定义。 还包括包含这些化合物的药物组合物,以及使用这些化合物和药物组合物治疗病症和障碍的方法。
-
-
-
-
-
-
-